Atea Pharmaceuticals Inc (AVIR)
$4.11 -4.64% Close Oct 30, 2026 Live
Atea Pharmaceuticals stock today
Atea Pharmaceuticals closed at $4.11 on October 30, 2026, down 4.64% on the day. Over the past year it returned +25.7% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $329 million.
$3.00$4.00$5.00$6.00
NovJan 2026MarMayJulSep
| Period | AVIR | S&P 500 (SPY) |
|---|---|---|
| 1 month | -21.1% | -0.9% |
| 3 months | -13.3% | +2.1% |
| Year to date | +15.1% | +11.7% |
| 1 year | +25.7% | +12.4% |
| 3 years | +32.6% | +88.5% |
| 5 years | -64.7% | +76.0% |
Key statistics
- Market value
- $329M
- 52-week range
- $2.96 to $6.15
- Next report
- Nov 11, 2026
About Atea Pharmaceuticals
Atea Pharmaceuticals develops antiviral treatments for infectious diseases including hepatitis C and respiratory infections.
Sector: Health Care
More on Atea Pharmaceuticals
- Returns: what $1,000 became$1,000 five years ago is $353.09 today
No forecast, no recommendation. This page describes Atea Pharmaceuticals Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.